Literature DB >> 6215894

Piperacillin distribution into bile, gallbladder wall, abdominal skeletal muscle, and adipose tissue in surgical patients.

J Russo, M I Thompson, M E Russo, B A Saxon, J M Matsen, F G Moody, L F Rikkers.   

Abstract

The concentrations of piperacillin in serum, bile, gallbladder wall, abdominal skeletal muscle, and adipose tissue were measured simultaneously at various times after the intravenous administration of a single 5-g dose to each of 14 patients undergoing biliary tract surgery. Piperacillin concentrated in the bile with peak levels exceeding 4,000 micrograms/ml. In a single patient with cystic duct obstruction, trace gallbladder bile piperacillin levels were measured. Gallbladder wall concentrations of piperacillin tended to be higher than corresponding serum concentrations, with a correlation observed between tissue values and the degree of acute gallbladder inflammation and gallbladder bile piperacillin concentrations. Mean peak muscle and adipose tissue piperacillin concentrations of 31 and 27 micrograms/g, respectively, were reached at between 2 and 3 h after the start of infusion. These concentrations exceeded the minimum inhibitory concentration for a majority of susceptible organisms. A single 5-g dose of piperacillin achieved therapeutic levels in gallbladder wall, intraabdominal skeletal muscle, and adipose tissue and concentrated in the bile of patients with patent biliary tracts.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215894      PMCID: PMC183770          DOI: 10.1128/AAC.22.3.488

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Interstitial fluid and serum antibiotic concentrations.

Authors:  N G Waterman; L B Kastan
Journal:  Arch Surg       Date:  1972-08

2.  Comparative evaluation of piperacillin in vitro.

Authors:  G M Dickinson; T J Cleary; T A Hoffman
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

3.  Methicillin distribution in serum and extravascular fluid and its relevance to normal and damaged heart valves.

Authors:  F M Gengo; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

4.  Biliary elimination of mezlocillin: an experimental and clinical study.

Authors:  J M Brogard; J Kopferschmitt; J P Arnaud; M Dorner; J La Villaureix
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

5.  Ampicillin levels in human bile in the presence of biliary tract disease.

Authors:  P R Mortimer; D B Mackie; S Haynes
Journal:  Br Med J       Date:  1969-07-12

6.  Piperacillin pharmacokinetics in subjects with chronic renal failure.

Authors:  M I Thompson; M E Russo; J M Matsen; E Atkin-Thor
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

  6 in total
  6 in total

1.  Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract.

Authors:  S J van den Hazel; X H de Vries; P Speelman; J Dankert; G N Tytgat; K Huibregtse; D J van Leeuwen
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

2.  The effect of piperacillin prophylaxis on the colonic microflora In patients undergoing colorectal surgery.

Authors:  L Kager; A S Malmborg; C E Nord; S Sjöstedt
Journal:  Infection       Date:  1983 Sep-Oct       Impact factor: 3.553

3.  Experimental studies of biliary excretion of piperacillin.

Authors:  P Calhoun; K B Brown; R Strunk; D A Krusch; W M Scheld; J B Hanks
Journal:  Ann Surg       Date:  1987-04       Impact factor: 12.969

4.  Pharmacokinetics of piperacillin in subjects with various degrees of renal function.

Authors:  P G Welling; W A Craig; R W Bundtzen; F W Kwok; A U Gerber; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

Review 5.  Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; D M Richards; R N Brogden; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

6.  Clinical Presentation and Incidence of Anaerobic Bacteria in Surgically Treated Biliary Tract Infections and Cholecystitis.

Authors:  Jens Strohäker; Lisa Wiegand; Christian Beltzer; Alfred Königsrainer; Ruth Ladurner; Anke Meier
Journal:  Antibiotics (Basel)       Date:  2021-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.